A sign stands outside a Bristol Myers Squibb facility in

Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push

A sign stands outside a Bristol Myers Squibb facility in Cambridge

FILE PHOTO: A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Copyright © 2024 Active Trader Daily - Succinct Financial News.
Copyright © 2024 Active Trader Daily - Succinct Financial News.